An Open, Dose-escalation Clinical Study Evaluating the Safety, Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema (DME) Patients in China
Latest Information Update: 06 May 2024
At a glance
- Drugs SKG-0106 (Primary)
- Indications Diabetic macular oedema
- Focus Adverse reactions
Most Recent Events
- 29 Apr 2024 Planned initiation date changed from 1 Jan 2024 to 1 May 2024.
- 06 Feb 2024 New trial record